Skip to main content
OpenTrials

Clinical trial condition

Thyroid Eye Disease

Explore clinical trials studying Thyroid Eye Disease. Study availability and eligibility vary by location and protocol.

50 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Thyroid Eye Disease trial results

Completed

Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)

NCT01297699

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +14 more
Locations
  • Hospital Clínico de Santiago Santiago de Compostela, A Coruña, Spain
  • Hospital Santa Creu i Sant Pau Barcelona, Spain
  • Hospital Clínico San Carlos Madrid, Spain
  • Hospital Universitario Ramón y Cajal Madrid, Spain
View Trial Details
Active, Not Recruiting

A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease

NCT06248619

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Catalina Eye Care - NVISION - PPDS Tucson, Arizona, United States
  • Advanced Quality Medical Research Orland Park, Illinois, United States
  • W Kellogg Eye Center Ann Arbor, Michigan, United States
  • Las Vegas Endocrinology Henderson, Nevada, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease

NCT06557850

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • University Clinical Center of The Republic Of Srpska Banja Luka, Republika Srpska, Bosnia and Herzegovina
  • Diagnostic-Consultative Center Alexandrovska Sofia, Bulgaria
  • University Specialized Hospital for Active Treatment in Endocrinology (USHATE) "Acad. Ivan Penchev" Sofia, Bulgaria
  • Jagiellonian University Medical College Krakow, Lesser Poland Voivodeship, Poland
View Trial Details
Active, Not Recruiting

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

NCT06625398

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Scottsdale Clinical Trials Scottsdale, Arizona, United States
  • Alliance Research Institute - Canoga Park Canoga Park, California, United States
  • Marvel Clinical Research Huntington Beach, California, United States
  • United Medical Research Institute Inglewood, California, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

NCT06106828

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Plastics-Orbit-Neuro San Diego, California, United States
  • Connecticut Eye Consultants, P.C. Danbury, Connecticut, United States
  • University of Illinois Eye and Ear Infirmary Chicago, Illinois, United States
  • Scheie Eye Institute Philadelphia, Pennsylvania, United States
View all 40 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease

NCT05987423

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +13 more
Locations
  • Thrive Health Research LLC Beverly Hills, California, United States
  • UCSD Shiley Eye Center La Jolla, California, United States
  • Grene Vision Group, LLC Wichita, Kansas, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease

NCT06088979

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Catalina Eye Care - Site 840-121 Tucson, Arizona, United States
  • Foothill Eye Institute - Site 840-116 Pasadena, California, United States
  • University of California Davis Eye Center - Site 840-119 Sacramento, California, United States
  • The Pacific Center for Oculofacial and Aesthetic Plastic Surgery - Site 840-122 San Francisco, California, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)

NCT06625411

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Scottsdale Clinical Trials Scottsdale, Arizona, United States
  • Alliance Research Institute - Canoga Park Canoga Park, California, United States
  • Marvel Clinical Research Huntington Beach, California, United States
  • United Medical Research Institute Inglewood, California, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

NCT05276063

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +20 more
Locations
  • Thrive Health Research Beverly Hills, California, United States
  • UC San Diego Health La Jolla, California, United States
  • UCLA Los Angeles, California, United States
  • Byers Eye Institute - Stanford University Palo Alto, California, United States
View all 30 locations
View Trial Details

Related conditions